![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, August 21, 2023 7:51:14 PM
On August 21, 2023, Elite Pharmaceuticals Inc (ELTP) experienced a significant surge in its stock performance. According to data from CNN Money, the one analyst offering a 12-month price forecast for ELTP has set a median target of $4.00, with both the high and low estimates also at $4.00. This forecast represents a staggering 5,417.24% increase from the last recorded price of $0.07.
The lack of available charts makes it difficult to analyze the stock’s performance in detail. However, the consensus among the one polled investment analyst is to buy ELTP stock. This rating has remained steady since January, indicating a consistent positive outlook for the company.
Elite Pharmaceuticals Inc is a pharmaceutical company that specializes in the development and manufacturing of generic and branded generic products. They focus on controlled-release drug delivery systems and abuse-deterrent technologies. The company’s primary goal is to improve patient outcomes by providing affordable and effective medications.
The optimistic forecast for ELTP stock suggests that investors have confidence in the company’s future prospects. The projected increase of over 5,000% indicates strong growth potential. However, it is important to note that analyst predictions are not always accurate, and stock market fluctuations can be unpredictable.
Investors considering purchasing ELTP stock should conduct thorough research and consider various factors, such as the company’s financial health, competitive landscape, and industry trends. It is also advisable to consult with a financial advisor to make informed investment decisions.
Overall, Elite Pharmaceuticals Inc’s stock performance on August 21, 2023, appears to be highly promising. With analysts predicting a substantial increase in value, the company’s future looks bright. However, investors should exercise caution and conduct their due diligence before making any investment decisions.
Recent ELTP News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2024 08:07:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/20/2024 08:30:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2024 09:55:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/29/2023 07:21:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/26/2023 09:20:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 09:20:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/28/2023 12:05:38 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 11:58:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 11:50:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration with ZenaDrone • InvestorsHub NewsWire • 11/16/2023 12:32:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/25/2023 08:15:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/07/2023 08:05:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 09:30:05 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 07/31/2023 08:20:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/17/2023 08:15:16 PM
FEATURED Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM